News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad
May 28, 2024, 14:05

Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:

“How applying FDA censoring rules can double the PFS benefit?

Nice coverage by Vinay Prasad in the Drug Development Letter of our paper recently published in EJC!”

Read the article.
Sources: Timothée Olivier/X
.

cancer cancer treatment efficacy clinical trial methodology Drug Development Letter EJC paper FDA censoring rules HUG - Geneva University Hospitals Medical Advancements OncoDaily Oncology oncology research progression-free survival (PFS) benefit regulatory guidelines Timothée Olivier Vinay Prasad
Special Coverage
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC
Insight
Nov 20, 2024, 19:12
Nareg Varjabedian: Antidiabetic Drugs and Cancer Prevention
Insight
Nov 20, 2024, 19:12
Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer
Insight
Nov 20, 2024, 19:12
Physicians’ perspectives on cancer-related fatigue management: A cross-sectional survey study in Germany - MASCC